LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.74% | 44.64% | -0.21% | -75.63% | 0.48% |
| Total Depreciation and Amortization | 0.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.70% | -98.86% | 0.19% | 198.89% | -0.46% |
| Change in Net Operating Assets | -- | -- | 0.22% | -- | -- |
| Cash from Operations | 2.74% | 15.73% | -0.21% | -32.14% | 0.48% |
| Capital Expenditure | 3.45% | -314.29% | 0.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.45% | -314.29% | 0.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | -- | -- | -100.00% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | -- | 100.00% | 0.00% |
| Cash from Financing | -2.75% | -- | -- | -100.00% | -0.47% |
| Foreign Exchange rate Adjustments | -- | -- | 0.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.75% | 1,179.38% | -0.20% | -168.61% | -0.48% |